Synoptic Analysis of the New York March 1888 Blizzard

The meteorological circumstances that led to the Blizzard of March 1888 that hit New York are analysed in Version 2 of the “Twentieth Century Reanalysis” (20CR). The potential of this data set for studying historical extreme events has not yet been fully explored. A detailed analysis of 20CR data alongside other data sources (including historical instrumental data and weather maps) for historical extremes such as the March 1888 blizzard may give insights into the limitations of 20CR. We find that 20CR reproduces the circulation pattern as well as the temperature development very well. Regarding the absolute values of variables such as snow fall or minimum and maximum surface pressure, there is anunderestimation of the observed extremes, which may be due to the low spatial resolution of 20CR and the fact that only the ensemble mean is considered. Despite this drawback, the dataset allows us to gain new information due to its complete spatial and temporal coverage.

Schiller und das Wiener Burgtheater. Don Karlos-Inszenierungen 1938 und 1955 als Beispiele

Der Beitrag untersucht anhand der Rezeption von zwei exemplarischen Don Karlos-Inszenierungen, die beide in politisch markanten Jahren der österreichischen Geschichte ihre Premiere erlebten, die Funktionalisierung der Institution Burgtheater in Verbindung mit der Funktionalisierung des Dramatikers Friedrich Schiller für eben diese Institution. Eine Neueinstudierung erfolgte 1938, dem Jahr von Österreichs ‚Anschluss’ an Nazi-Deutschland, die andere 1955, dem Jahr der Unterzeichnung des Österreichischen Staatsvertrages. Beide Don Karlos-Inszenierungen fanden als spezifische Festvorstellungen im Rahmen von Feierlichkeiten rund um die Institution Burgtheater statt. Diente 1938 Schillers Don Karlos dazu, als ‚Schlüsselstück’ der ‚nationalsozialistischen Revolution’ einen politisch-gesellschaftlichen Aufbruch zu markieren, so wurde 1955 die Inszenierung des Dramas zum Triumph einer Schauspielerelite, deren Können sich in die konstruierte Tradition eines k.k. ‚Schauspieleradels’ einreihte. Während 1938 der ‚nationale Dichter’ dem ‚heimgekehrten’ Nationaltheater zum ästhetischen ‚Anschluss’ verhalf, diente der ‚überzeitliche’ Klassiker 1955 dazu, eine ästhetische ‚Wiedergeburt’ zu behaupten, die dem restaurativen Kunst- und Kulturbegriff Nachkriegsösterreichs verpflichtet war.

The Swiss Canine Cancer Registry: a retrospective study on the occurrence of tumours in dogs in Switzerland from 1955 to 2008

Diagnostic records are a key feature of any cancer epidemiology, prevention or control strategy for man and animals. Therefore, the information stored in human and animal cancer registries is essential for undertaking comparative epidemiological, pathogenic and therapeutic research. This study presents the Swiss Canine Cancer Registry, containing case data compiled between 1955 and 2008. The data consist of pathology diagnostic records issued by three veterinary diagnostic laboratories in Switzerland. The tumours were classified according to the guidelines of the International Classification of Oncology for Humans on the basis of tumour type, malignancy and body location. The dogs were classified according to breed, age, sex, neuter status and place of residence. The diagnostic data were correlated with data on the Swiss general dog population and the incidence of cancer in dogs was thus investigated. A total of 67,943 tumours were diagnosed in 121,963 dogs and 47.07% of these were malignant. The most common tumour location was the skin (37.05%), followed by mammary glands (23.55%) and soft tissue (13.66%). The most common tumour diagnoses were epithelial (38.45%), mesenchymal (35.10%) and lymphoid tumours (13.23%). The results are compared with data in other canine registries and similarities in tumour distribution and incidence are noted. It is hoped that this study will mark the beginning of continuous registration of dog tumours in Switzerland, which, in turn, will serve as a reference for research in the fields of animal and human oncology.